Loading…
Tulasee Bio-Ethanol (BSE 524514)₹31.350.00%Commodity Chemicals
In the Jun 2026 quarter (standalone), Tulasee Bio-Ethanol reported sales of ₹0 Cr and net profit of −₹0.07 Cr. For the year to Mar 2026, sales were ₹0 Cr and net profit −₹0.19 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.03 | 0.05 | 0.04 | 0.07 | 0.03 | 0.03 | 0.05 | 0.08 | 0.04 | 0.05 | 0.05 | 0.07 |
| Operating Profit | −0.01 | −0.03 | −0.02 | −0.05 | −0.01 | −0.01 | −0.03 | −0.06 | −0.02 | −0.03 | −0.03 | −0.05 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.03 | −0.05 | −0.04 | −0.07 | −0.03 | −0.03 | −0.05 | −0.08 | −0.04 | −0.05 | −0.05 | −0.07 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | −0.03 | −0.05 | −0.04 | −0.07 | −0.03 | −0.03 | −0.05 | −0.08 | −0.04 | −0.05 | −0.05 | −0.07 |
| EPS (Rs) | −0.04 | −0.08 | −0.06 | −0.11 | −0.04 | −0.04 | −0.08 | −0.13 | −0.06 | −0.08 | −0.08 | −0.11 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.02 | 0.13 | 0.18 | 0.18 | 0.58 | 0.16 | 0.15 | 0.14 | 0.14 | 0.14 | 0.19 | 0.21 |
| Operating Profit | 0.00 | −0.11 | −0.16 | −0.16 | −0.56 | −0.14 | −0.13 | −0.12 | −0.12 | −0.12 | −0.17 | −0.13 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 1.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.05 | −0.13 | −0.18 | −0.18 | 0.49 | −0.16 | −0.15 | −0.14 | −0.14 | −0.14 | −0.19 | −0.21 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Net Profit | −0.05 | −0.13 | −0.18 | −0.18 | 0.49 | −0.16 | −0.15 | −0.14 | −0.14 | −0.14 | −0.19 | −0.21 |
| EPS (Rs) | −0.08 | −0.21 | −0.30 | −0.30 | 0.82 | −0.26 | −0.25 | −0.23 | −0.23 | −0.23 | −0.32 | −0.33 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.84 | 5.84 | 5.85 | 5.84 | 5.84 | 5.85 | 5.84 | 5.85 | 5.85 | 5.84 | 5.84 | 5.85 |
| Reserves | −4.43 | −4.47 | −4.58 | −4.76 | −4.92 | −4.44 | −4.61 | −4.74 | −4.87 | −5.00 | −5.13 | −5.12 |
| Borrowings | 5.37 | 5.46 | 6.55 | 6.70 | 6.88 | 6.65 | 6.82 | 6.94 | 7.09 | 7.22 | 7.38 | 0.00 |
| Other Liabilities | 0.62 | 0.57 | 0.55 | 0.57 | 0.56 | 0.30 | 0.33 | 0.32 | 0.31 | 0.34 | 0.32 | 7.68 |
| Total Liabilities | 7.40 | 7.40 | 8.37 | 8.35 | 8.36 | 8.36 | 8.38 | 8.37 | 8.38 | 8.40 | 8.41 | 8.41 |
| Fixed Assets | 4.69 | 4.69 | 4.69 | 4.69 | 4.69 | 4.69 | 4.69 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 2.71 | 2.71 | 3.68 | 3.66 | 3.67 | 3.67 | 3.69 | 3.71 | 3.72 | 3.74 | 3.75 | 3.75 |
| Inventories | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Cash & equivalents | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 7.40 | 7.40 | 8.37 | 8.35 | 8.36 | 8.36 | 8.38 | 8.37 | 8.38 | 8.40 | 8.41 | 8.41 |
| Mar 2019 | Mar 2022 | |
|---|---|---|
| Cash from operating activity | −0.18 | −0.04 |
| Cash from investing activity | 0.18 | 0.04 |
| Cash from financing activity | 0.00 | 0.00 |
| Net cash flow | 0.00 | 0.00 |
| Free cash flow | −0.18 | 0.00 |
| CFO / OP % | 100.0% | 21.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 0.0% | −0.2% | −1.7% | −2.2% | −2.2% | 6.0% | −1.9% | −1.8% | −1.6% | −1.6% | −1.6% | −4.1% |
For the Jun 2026 quarter, Tulasee Bio-Ethanol reported sales of ₹0 Cr and net profit of −₹0.07 Cr.
Tulasee Bio-Ethanol's sales for the year to Mar 2026 were ₹0 Cr; over the last twelve months they were ₹0 Cr.
Net profit for the year to Mar 2026 was −₹0.19 Cr, and −₹0.21 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.33.
Tulasee Bio-Ethanol reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0 Cr.
Cash from operations was −₹0.04 Cr in the year to Mar 2022; after capital spending, free cash flow was ₹0 Cr.